By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeuroVive Pharmaceutical AB 

Biomedical Center

Sölvegatan 19    SE-221 84 Lund  Sweden
Phone: 46-0-46-288-0110 Fax: 46-0-46-888-8348



Company News
NeuroVive (NVP) Reports Favourable Safety Evaluation In Phase II Acute Kidney Injury Study 11/19/2015 11:50:02 AM
NeuroVive (NVP): Interim Report 1 Jan. 2015 To 30 Sep. 2015 11/18/2015 9:57:18 AM
NeuroVive (NVP): NeuroVive Presents Findings Targeting Complex I Deficiency At World Mitochondria Congress 11/2/2015 1:48:27 PM
NeuroVive (NVP)'s OCB-030 Preclinical Program Has Been Discontinued By Arbutus Biopharma (ABUS) 10/28/2015 6:42:34 AM
NeuroVive (NVP) Strengthens Clinical Development Team With Appointment Of Dr. Magnus Hansson As Chief Medical Officer 10/23/2015 10:47:08 AM
NeuroVive (NVP): Annual General Meeting 2016 And Nomination Committee 10/16/2015 10:48:19 AM
NeuroVive (NVP) Chief Executive Brönnegârd Replaced After Stocks Tank and Clinical Trial Falters 9/1/2015 6:52:06 AM
NeuroVive Discontinues Ciclomulsion for Myocardial Infarction 8/31/2015 6:26:46 AM
NeuroVive Share upgraded On OTC Market In U.S. 6/26/2015 2:25:26 PM
NeuroVive: Neurovive Reports Topline Results Of Phase III CIRCUS Study In Acute Myocardial Infarction 6/1/2015 11:19:22 AM